Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

OBJECTIVES: We investigated determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike IgG responses in healthcare workers (HCWs) following one or two doses of Pfizer–BioNTech or Oxford–AstraZeneca vaccines. METHODS: HCWs participating in regular SARS-CoV-2 PCR and antib...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Microbiol Infect
Egile Nagusiak: Eyre, David W., Lumley, Sheila F., Wei, Jia, Cox, Stuart, James, Tim, Justice, Anita, Jesuthasan, Gerald, O'Donnell, Denise, Howarth, Alison, Hatch, Stephanie B., Marsden, Brian D., Jones, E. Yvonne, Stuart, David I., Ebner, Daniel, Hoosdally, Sarah, Crook, Derrick W., Peto, Tim E.A., Walker, Timothy M., Stoesser, Nicole E., Matthews, Philippa C., Pouwels, Koen B., Walker, A. Sarah, Jeffery, Katie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8180449/
https://ncbi.nlm.nih.gov/pubmed/34111577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2021.05.041
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak